Table 1: Pharmacokinetic and -dynamic characteristics of recombinant human intact parathyroid hormone ( ) and teriparatide ( ) following a subcutaneous injection into the abdominal skin [32].

PTH analogue

Bioavailability (%)95%55%
Time to peak PTH level (hours)0.5 h1-2 h
Plasma half-life (hours)1.0 h1.5 h
Time to peak plasma calcium levels (hours)4–6 h6–8 h

The data in the table are derived from EMEA online (http://www.ema.europa.eu/ema/). EMA Preotact product description and EMA Forsteo product description.